The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-cyclopropyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-yl)phenoxy)-N-(1-methylcyclopropyl)acetamide ID: ALA4645036
PubChem CID: 156018848
Max Phase: Preclinical
Molecular Formula: C31H33N7O2
Molecular Weight: 535.65
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1(NC(=O)COc2cccc(-c3nc4c(c(Nc5ccc(-c6cn[nH]c6)cc5)n3)CN(C3CC3)CC4)c2)CC1
Standard InChI: InChI=1S/C31H33N7O2/c1-31(12-13-31)37-28(39)19-40-25-4-2-3-21(15-25)29-35-27-11-14-38(24-9-10-24)18-26(27)30(36-29)34-23-7-5-20(6-8-23)22-16-32-33-17-22/h2-8,15-17,24H,9-14,18-19H2,1H3,(H,32,33)(H,37,39)(H,34,35,36)
Standard InChI Key: AMQJEAXSVOXATE-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 46 0 0 0 0 0 0 0 0999 V2000
23.9503 -25.7539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3630 -26.4638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7714 -25.7514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9697 -26.9040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6835 -26.4904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6806 -25.6636 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9679 -25.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9655 -24.4370 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6761 -24.0222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3829 -24.4352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0930 -24.0210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0910 -23.1988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3730 -22.7925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6699 -23.2049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7955 -22.7888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5476 -23.1180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0959 -22.5042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6801 -21.7941 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8775 -21.9717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3883 -26.9012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3883 -27.7237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0999 -28.1311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8121 -27.7213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8081 -26.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0959 -26.4879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5179 -26.4794 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.2318 -26.8886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9415 -26.4722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9374 -25.6509 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.6555 -26.8813 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2575 -26.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2616 -25.6717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5581 -25.2609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8461 -25.6646 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8420 -26.4838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5500 -26.8992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0757 -26.8687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1412 -25.2544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7371 -24.5441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3240 -25.2491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
1 3 1 0
31 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 32 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 15 2 0
12 15 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
5 20 1 0
24 26 1 0
26 27 1 0
27 28 1 0
28 29 2 0
28 30 1 0
30 2 1 0
31 32 2 0
31 36 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
2 37 1 0
39 38 1 0
40 39 1 0
38 40 1 0
34 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 535.65Molecular Weight (Monoisotopic): 535.2696AlogP: 4.85#Rotatable Bonds: 9Polar Surface Area: 108.06Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.78CX Basic pKa: 6.96CX LogP: 4.13CX LogD: 3.99Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.28Np Likeness Score: -1.27
References 1. Liu KG, Kim JI, Olszewski K, Barsotti AM, Morris K, Lamarque C, Yu X, Gaffney J, Feng XJ, Patel JP, Poyurovsky MV.. (2020) Discovery and Optimization of Glucose Uptake Inhibitors., 63 (10): [PMID:32282207 ] [10.1021/acs.jmedchem.9b02153 ]